A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Clinical trial NCT03481660 · COMPLETED
Trial details
- NCT number
- NCT03481660
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-27
- Primary completion
- 2020-06-29
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.